How much does lamivudine dolutegravir tablets (Dovito) cost?
Lamivudine/Dolutegravir is a combination antiretroviral therapy (ART) drug used to treat human immunodeficiency virus (HIV) infection. The drug is a fixed-dose combination of two different classes of anti-HIV drugs, lamivudine and dolutegravir, and different formulations of the two drugs that can be used to meet different patient needs.
Lamivudine dolutegravir tablets have been launched in China and have been included in medical insurance. Patients can buy them in domestic hospital pharmacies at a price of about more than 1,000 yuan. Please consult the local hospital pharmacy for specific prices and reimbursement information. The cheaper ones abroad are mainly Indian generic drugs, which cost more than 200 yuan, and the ingredients of domestic original drugs and foreign generic drugs are basically the same.

The combined use of lamivudine and dolutegravir tablets can help reduce the number of times that HIV infected people need to take multiple drugs every day and improve patient compliance. In addition, this drug can be used to replace traditional three-drug combination therapy, thus simplifying treatment options.
Lamivudine dolutegravir tablets are generally considered to be a highly effective and relatively safe antiHIV treatment drug. However, patients should follow their doctor's advice and prescriptions when using it, as it may cause some side effects, such as headache, nausea, diarrhea, etc. In addition, some patients may be allergic to certain ingredients in the drug, so doctors often perform genetic testing to evaluate whether the drug is appropriate.
In short, lamivudine dolutegravir tablets are a combined antiretroviral drug used to treat HIV infection. It combines two different types of antiHIV drugs to help effectively inhibit viral replication, maintain immune system function, and improve patients' quality of life. Patients should use the drug correctly under the supervision of a doctor and undergo regular medical monitoring.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)